A Drug Release Model Constructed by Factorial Design to Investigate the Interaction Between Host Mesoporous Silica Carriers and Drug Molecules

被引:5
作者
Liu, Tong [1 ,2 ]
Wang, Keke [1 ,2 ]
Jiang, Mingyan [1 ,2 ]
Wan, Long [1 ,2 ]
机构
[1] China Med Univ, Hosp 1, Dept Pharm, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China
[2] China Med Univ, Sch Pharm, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China
基金
中国国家自然科学基金;
关键词
mesocellular foam silica; factorial design; drug release; MESOCELLULAR FOAM; IN-VITRO; ORAL BIOAVAILABILITY; DELIVERY SYSTEM; PORE-SIZE; NANOPARTICLES; WATER; ADSORPTION; CHITOSAN; OPTIMIZATION;
D O I
10.1208/s12249-019-1340-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A drug release model based on mesocellular foam silica (MCF) for Biopharmaceutics Classification System (BCS) II drugs was conducted. A three-level two-factorial factorial design was carried out for the exploration of the influence of the pore size of MCF (X-1) and drug-loading degree (X-2) for drug release behaviors. Cumulative release in 1h (Y-1), cumulative release in 24h (Y-2), and rate constant k (Y-3) were selected as dependent response variables. A series of MCFs (7MCF, 12MCF, and 17MCF) with arithmetic increased pore diameters was synthesized as drug carriers. The morphologies and structures of MCFs and pore size distributions were detected by scanning electron microscopy, transmission electron microscopy, and nitrogen adsorption analysis. With celecoxib as a model drug, nine drug-loaded samples were prepared and further characterized by differential scanning calorimetry and X-ray diffraction analyses. The release behavior was examined by in vitro dissolution. Factorial design results demonstrated that cumulative release in 1h and the rate constant k were mainly affected by X-2, while cumulative release in 24h was influenced by both X-1 and X-2. Furthermore, quadratic equations of Y-1, Y-2, and Y-3 were conducted, respectively. This work was expected to provide some scientific references for designing specific drug delivery models with mesoporous silica carrier.
引用
收藏
页数:9
相关论文
共 52 条
[1]   A molecularly imprinted dual-emission carbon dot-quantum dot mesoporous hybrid for ratiometric determination of anti-inflammatory drug celecoxib [J].
Amjadi, Mohammad ;
Jalili, Roghayeh .
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2018, 191 :345-351
[2]   Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices [J].
Andersson, J ;
Rosenholm, J ;
Areva, S ;
Lindén, M .
CHEMISTRY OF MATERIALS, 2004, 16 (21) :4160-4167
[3]   Carbon Dioxide Sorbents with Propylamine Groups-Silica Functionalized with a Fractional Factorial Design Approach [J].
Aziz, Baroz ;
Zhao, Guoying ;
Hedin, Niklas .
LANGMUIR, 2011, 27 (07) :3822-3834
[4]   A NEW FAMILY OF MESOPOROUS MOLECULAR-SIEVES PREPARED WITH LIQUID-CRYSTAL TEMPLATES [J].
BECK, JS ;
VARTULI, JC ;
ROTH, WJ ;
LEONOWICZ, ME ;
KRESGE, CT ;
SCHMITT, KD ;
CHU, CTW ;
OLSON, DH ;
SHEPPARD, EW ;
MCCULLEN, SB ;
HIGGINS, JB ;
SCHLENKER, JL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (27) :10834-10843
[5]   Mesoporous silica nanoparticles in target drug delivery system: A review [J].
Bharti, Charu ;
Nagaich, Upendra ;
Pal, Ashok Kumar ;
Gulati, Neha .
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2015, 5 (03) :124-133
[6]   Inclusion and Release of Fenbufen in Mesoporous Silica [J].
Carriazo, Daniel ;
Del Arco, Margarita ;
Fernandez, Alicia ;
Martin, Cristina ;
Rives, Vicente .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (08) :3372-3380
[7]   Synthesis of large-pore mesostructured cellular foam silica spheres for the adsorption of biomolecules [J].
Chen, Sha ;
Sun, Shaoai ;
Zhang, Xiaoqiong ;
Han, Qiang ;
Yang, Liu ;
Ding, Mingyu .
JOURNAL OF SEPARATION SCIENCE, 2014, 37 (17) :2411-2417
[8]   Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration [J].
Czarnobaj, Katarzyna ;
Prokopowicz, Magdalena ;
Sawicki, Wiesaw .
AAPS PHARMSCITECH, 2017, 18 (08) :3163-3171
[9]   Mesoporous Calcium Carbonate as a Phase Stabilizer of Amorphous Celecoxib - An Approach to Increase the Bioavailability of Poorly Soluble Pharmaceutical Substances [J].
Forsgren, Johan ;
Andersson, Mattias ;
Nilsson, Peter ;
Mihranyan, Albert .
ADVANCED HEALTHCARE MATERIALS, 2013, 2 (11) :1469-1476
[10]  
Ganesh M., 2013, Int J Control Autom Syst, V6, P207, DOI DOI 10.14257/ijca.2013.6.5.20